DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftfagfællebedømt

Standard

DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL. / Grøn, Kathrine; Glintborg, Bente; Nørgaard, Mette; Mehnert, Frank; Stergaard, Mikkel; Dreyer, Lene; Krogh, Niels Steen; Bjørner, Jakob Bue; Hetland, Merete L.

I: Annals of the Rheumatic Diseases, Bind 78, Nr. Suppl 2, SAT0595, 2019, s. 1391-1391.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftfagfællebedømt

Harvard

Grøn, K, Glintborg, B, Nørgaard, M, Mehnert, F, Stergaard, M, Dreyer, L, Krogh, NS, Bjørner, JB & Hetland, ML 2019, 'DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL', Annals of the Rheumatic Diseases, bind 78, nr. Suppl 2, SAT0595, s. 1391-1391. https://doi.org/10.1136/annrheumdis-2019-eular.2039

APA

Grøn, K., Glintborg, B., Nørgaard, M., Mehnert, F., Stergaard, M., Dreyer, L., Krogh, N. S., Bjørner, J. B., & Hetland, M. L. (2019). DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL. Annals of the Rheumatic Diseases, 78(Suppl 2), 1391-1391. [SAT0595]. https://doi.org/10.1136/annrheumdis-2019-eular.2039

Vancouver

Grøn K, Glintborg B, Nørgaard M, Mehnert F, Stergaard M, Dreyer L o.a. DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL. Annals of the Rheumatic Diseases. 2019;78(Suppl 2):1391-1391. SAT0595. https://doi.org/10.1136/annrheumdis-2019-eular.2039

Author

Grøn, Kathrine ; Glintborg, Bente ; Nørgaard, Mette ; Mehnert, Frank ; Stergaard, Mikkel ; Dreyer, Lene ; Krogh, Niels Steen ; Bjørner, Jakob Bue ; Hetland, Merete L. / DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL. I: Annals of the Rheumatic Diseases. 2019 ; Bind 78, Nr. Suppl 2. s. 1391-1391.

Bibtex

@article{9f974955e3b040bbbb894640a5c9c3a8,
title = "DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL",
author = "Kathrine Gr{\o}n and Bente Glintborg and Mette N{\o}rgaard and Frank Mehnert and Mikkel Stergaard and Lene Dreyer and Krogh, {Niels Steen} and Bj{\o}rner, {Jakob Bue} and Hetland, {Merete L.}",
year = "2019",
doi = "10.1136/annrheumdis-2019-eular.2039",
language = "English",
volume = "78",
pages = "1391--1391",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "Suppl 2",

}

RIS

TY - ABST

T1 - DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

AU - Grøn, Kathrine

AU - Glintborg, Bente

AU - Nørgaard, Mette

AU - Mehnert, Frank

AU - Stergaard, Mikkel

AU - Dreyer, Lene

AU - Krogh, Niels Steen

AU - Bjørner, Jakob Bue

AU - Hetland, Merete L.

PY - 2019

Y1 - 2019

U2 - 10.1136/annrheumdis-2019-eular.2039

DO - 10.1136/annrheumdis-2019-eular.2039

M3 - Conference abstract in journal

VL - 78

SP - 1391

EP - 1391

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl 2

M1 - SAT0595

ER -

ID: 238533512